Charles M. Rudin MD, PhD

Charles Rudin is a board-certified medical oncologist specializing in the care of patients with lung cancer. In addition to serving as Chief of the Thoracic Oncology Service at Memorial Sloan Kettering Cancer Center, He co-chairs the Eastern Cooperative Oncology Group Thoracic Committee and is a member of the National Cancer Institute Thoracic Malignancies Steering Committee.

Charles Rudin is direct a broad research program of therapeutic research with the ultimate goal of improving the outcome for patients with lung cancer. His research includes laboratory-based investigations to identify and test novel treatment approaches to lung cancer, early-phase clinical trials to bring these ideas to the clinic, and later-phase studies to establish the efficacy of these new approaches. He is interested in small cell and non-small cell lung cancers. Some of the strategies my group has explored both in the laboratory and in the clinic include turning back on genes silenced in cancer, re-activating cancer cell death pathways, and treating lung cancer with a cancer-specific virus.